Monitoring Agency Report for the Quarter ended March 31, 2026
FABTECH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fabtech Technologies Limited, a pharmaceutical engineering company, filed its Q4 FY2026 monitoring agency report for its IPO proceeds. The company raised Rs 23,029.65 lakhs (gross) in its October 2025 IPO. Of the net proceeds of Rs 20,752.02 lakhs, only Rs 2,872.24 lakhs (about 14%) has been utilized so far — Rs 2,747.24 lakhs for working capital and Rs 125 lakhs for general corporate purposes. There is a delay in working capital utilization: the prospectus planned Rs 6,600 lakhs for FY2026 but only Rs 2,747.24 lakhs was used because internal accruals temporarily met working capital needs. No funds have been deployed for inorganic growth through acquisitions yet. Rs 17,921.96 lakhs remains unutilized, invested in fixed deposits with IndusInd Bank, Axis Bank, and ICICI Bank, earning Rs 256.70 lakhs in interest. Related party transactions of Rs 724.51 lakhs for raw materials were noted during the quarter.
The slow utilization of IPO proceeds, particularly for working capital and acquisitions, may concern investors expecting faster deployment. However, the funds are safely parked in FDs and the delay is attributed to internal accruals meeting needs first, which is not necessarily negative.